SCHEMBL6982218

SCHEMBL6982218

O=S(=O)(Nc1ccc2c(c1)CCCN2)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 5/20 0.56
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
CA9 Q16790 1/20 0.53
CES1 P23141 1/20 0.53
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
DRD2 P14416 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
CYP2C19 P33261 1/20 0.52
DRD3 P35462 1/20 0.52
HTR6 P50406 1/20 0.52
CYP19A1 P11511 1/20 0.51
ESR1 P03372 1/20 0.51
PNMT P11086 1/20 0.51
MLNR O43193 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985319 0.87 CA12 (0.53) PKMCA12CA1CA2CA9
SCHEMBL6986758 0.87 PKM (0.56) PKMCA12CA1CA2CA9
SCHEMBL6985107 0.87 LMNA (0.67) PKMCA12CA1CA2CA9
SCHEMBL6984820 0.87 HTR6 (0.61) PKMCA12CA1CA2CA9
SCHEMBL6983859 0.86 PKM (0.56) PKMLMNAMAPT
SCHEMBL31681377 0.85 EIF2AK2 (0.54) PKMCA12CA1CA2CA9
SCHEMBL11948477 0.82 CYP3A4 (0.51) PKMCYP3A4CYP2D6HTR6PNMT
SCHEMBL6976538 0.81 PKM (0.65) PKMCA12CA1CA2CA9
SCHEMBL2283294 0.80 CA1 (0.60) PKMCA12CA1CA2CA9
SCHEMBL6974134 0.79 HSD17B2 (0.50) PKMCA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed